Searched for
BAYER CONSUMER HEALTH
Bayer bets big on 'self-care' market to deepen India playGlobal pharma major Bayer is significantly expanding its consumer healthcare presence in India, targeting the burgeoning self-care market e...
'India has intellectual power to be a leader in biomedical innovation,' says Bayer AGBayer's CEO Bill Anderson believes India can become a top pharmaceutical market. He highlights the need for supportive policy frameworks, i...
Bayer says it has cut 12,000 jobs so far under restructuring pushBayer has eliminated approximately 12,000 full-time positions as part of its restructuring efforts aimed at streamlining operations and red...
Matthias Berninger on COP28: Prioritizing impact over pledgesThe former German politician and member of the Greens says that “a kind of COP related nervousness and energy” around commitments is “somet...
Bayer, GenZero, and Shell India join hands to showcase scalability of methane emissions reduction in rice cultivationBayer, GenZero, and Shell Energy India are forming a partnership to create a scalable model for reducing methane emissions in rice cultivat...
Bayer's consumer health unit plans to step up India playIn an interview to ET, Sandeep Verma, country head, India, Bayer consumer health division in India, said the company will use its global ex...
'Bayer's digital solutions will boost farmers' lives'Our ability to contribute towards making these dreams become reality starts with access to our products across our entire portfolio. Our la...
Bayer launches Consumer Health division in India"The brands Saridon and Supradyn licensed to Piramal Consumer Products division in the past, have been transitioned back to Bayer's new Con...
Amazon top recruiter with 14 offers in second cluster of IIM Ahmedabad summer placementsConsumer Goods & durables firms included regular recruiters like AB InBev, Asian Paints, Coca-Cola, Colgate, Dabur, HUL, ITC, Kimberly Clar...
Big pharma returning to US price hikes in January after pausePfizer has already announced plans to hike prices on 41 of its drugs in mid-January.
Bayer Wins US Approval Russian Journalist to Buy MonsantoThe agreement requires the sale of assets to BASF SE that Bayer has previously announced. The divestiture package is worth about $9 billion...
Swadeshi test for GM MustardMahajan said that the general feeling in the Rashtriya Swayamsevak Sangh was against GM.
Reckitt may consider buying Pfizer's unitReckitt Benckiser Group would consider acquiring Pfizer's consumer-health unit were it to come up for sale in the wake of the Viagra maker'...
Soon, cancer medicines, stents to be cheaperAfter the feedback, the health ministry decided to extend CGHS kind of mechanism to cancer medicines and stents for other consumers also, t...
Reckitt's Rakesh Kapoor makes a mark with focus on consumer healthcareThough Kapoor still faces challenges with the home-care division and slowing growth in some emerging markets, the stock has risen 60% since...
- Patented drug launches could be delayed in India: Deloitte
Launch of patented drugs in India could be delayed due to the government's "thought process on linking patented drug prices to the country'...
- Cadila Healthcare targets revenues of $ 3 billion by 2015
After a subdued performance in the first nine months of FY12, Cadila Healthcare logged an improved show for the quarter ended March 2012.
Natco victory could encourage other generic companies also to apply for compulsory licenceEarlier this week, a ruling effectively cut the price of high-cost cancer drug Sorafenib by 97%. But that’s just one of many legal battles ...
- Bayer net quadruples to $1.7 b in Q3
Drug and chemical maker Bayer said Tuesday that its third-quarter profit nearly quadrupled with help from a massive tax gain, and lifted it...
- GSK to offer $15 bn for Pfizer unit: report
The British-based pharmaceutical group GlaxoSmithKline (GSK) is planning to offer more than $15 billion dollars for the consumer health car...